Margaret B McEntegart

Summary

Country: UK

Publications

  1. ncbi request reprint Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide
    Margaret B McEntegart
    BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, UK
    Eur Heart J 28:829-35. 2007
  2. ncbi request reprint Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program
    Tim Clayton
    Western Infirmary, Glasgow, Scotland, UK
    Circulation 115:3111-20. 2007
  3. ncbi request reprint Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program
    Eileen O'Meara
    Western Infirmary, Glasgow, UK
    Circulation 113:986-94. 2006

Detail Information

Publications3

  1. ncbi request reprint Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide
    Margaret B McEntegart
    BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, UK
    Eur Heart J 28:829-35. 2007
    ..Adiponectin concentration is inversely related to body weight and, in animals, causes weight loss. We, therefore, measured adiponectin concentration in patients with heart failure (HF) and cachexia...
  2. ncbi request reprint Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program
    Tim Clayton
    Western Infirmary, Glasgow, Scotland, UK
    Circulation 115:3111-20. 2007
    ....
  3. ncbi request reprint Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program
    Eileen O'Meara
    Western Infirmary, Glasgow, UK
    Circulation 113:986-94. 2006
    ..We wished to determine the prevalence of, potential mechanistic associations of, and clinical outcomes related to anemia in patients with heart failure and a broad spectrum of left ventricular ejection fraction (LVEF)...